A Pharmacological Update of Ellagic Acid

Abstract

Ellagic acid is a common metabolite present in many medicinal plants and vegetables. It is present either in free form or as part of more complex molecules (ellagitannins), which can be metabolized to liberate ellagic acid and several of its metabolites, including urolithins. While ellagic acidʼs antioxidant properties are doubtless responsible for many of its pharmacological activities, other mechanisms have also been implicated in its various effects, including its ability to reduce the lipidemic profile and lipid metabolism, alter pro-inflammatory mediators (tumor necrosis factor-α, interleukin-1β, interleukin-6), and decrease the activity of nuclear factor-κB while increasing nuclear factor erythroid 2-related factor 2 expression. These events play an important role in ellagic acidʼs anti-atherogenic, anti-inflammatory, and neuroprotective effects. Several of these activities, together with the effect of ellagic acid on insulin, glycogen, phosphatases, aldose reductase, sorbitol accumulation, advanced glycation end-product formation, and resistin secretion, may explain its effects on metabolic syndrome and diabetes. In addition, results from recent research have increased the interest in ellagic acid, both as a potential protective agent of the liver and skin and as a potential anticancer agent, due to the specific mechanisms affecting cell proliferation, apoptosis, DNA damage, and angiogenesis and its aforementioned anti-inflammatory properties. Taken together, these effects make ellagic acid a highly interesting compound that may contribute to different aspects of health; however, more studies are needed, especially on the compoundʼs pharmacokinetic profile. In this review, we selected papers published from 2005 to the present.

Supplementation of by‐products from grape, tomato and myrtle affects antioxidant status of dairy ewes and milk fatty acid profile

“…The EMB has a high polyphenol content (Table ), composed mainly of hydrolysable tannins and, to a lesser extent, of ellagic and gallic acids (3,724, 495 and 386 µg/g of EMB dry matter respectively; Nudda et al, ). Both ellagic acid (Derosa, Maffioli, & Sahebkar, ; Rios Giner, Marín, & Recio, ) and gallic acid (Rajan and Muraleedharan, ) have considerable antioxidant capacity, but probably the amount supplied with EMB may have been partly hydrolysed in the digestive tract (Kumar, Kumar, & Kaur, ; Kawabata, Yoshioka, & Terao, ).…”

Aplicações Tecnológicas De Bioaditivos Alimentares E Efeitos Sobre Fatores De Transcrição Gênica

“…Como alternativa para evitar essas modificações no produto, existe atualmente a utilização dos fitoquímicos (polifenóis, flavonoides, taninos, alcalóides, terpenóides, isotiocianatos, lectinas e polipeptídeos) extraídos de plantas que possuem ação antimicrobiana RÍOS et al, 2018) e são potentes agentes antioxidantes (ALVES et al, 2016;GOKOGLU, 2018;PEREIRA-FREIRE et al, 2018 Vale ainda destacar a utilização da transgenia aplicada à indústria de alimentos.…”

Epigenetic treatment of dermatologic disorders

“…Nrf2‐activating compounds are becoming staple ingredients in topically applied skin‐conditioning creams and other formulations that mitigate skin damage (Ahmed, ; Ben‐Nun, ; Braidy et al, ; Burke, ; Davinelli, Nielsen, & Scapagnini, ; Gorini et al, ; Huang, Wang, Yang, Chou, & Fang, ; Kocot, Kiełczykowska, Luchowska‐Kocot, Kurzepa, & Musik, ; Kunnumakkara et al, ; Lephart, ; Ríos, Giner, Marín, & Recio, ; Rodríguez‐Luna et al, ; Simitzis, ; Vega et al, , ; Vollmer et al, ; Yang et al, ; Yokota, Yahagi, & Masaki, ), promote skin repair (Bellot et al, ; Davinelli, Nielsen, & Scapagnini, ; Ferreira & Gomes, ; Kim et al, ; Yang et al, ), and enhance diabetic‐associated wound healing (Bellot et al, ; Ben‐Nun, ; Cuadrado et al, ; Ferreira & Gomes, ; Gorini et al, ; Huang et al, ; Kim et al, ; Kocot et al, ; Kunnumakkara et al, ; Panahi et al, ; Ríos et al, ; Sanchez, Lancel, Boulanger, & Neviere, ; Vega et al, ; Vega et al, ; Vollmer et al, ). With respect to the latter, almost a third of the world's population is considered to be overweight or obese (González‐Muniesa et al, ) and the percentage is rising to epidemic proportions (Blaszczak et al, ; Severin, Sabbahi, Mahmoud, Arena, & Phillips, ).…”

“…Nrf2-activating compounds are becoming staple ingredients in topically applied skin-conditioning creams and other formulations that mitigate skin damage (Ahmed, 2019;Ben-Nun, 2018;Braidy et al, 2019;Burke, 2018;Davinelli, Nielsen, & Scapagnini, 2018;Gorini et al, 2019;Huang, Wang, Yang, Chou, & Fang, 2018;Kocot, Kiełczykowska, Luchowska-Kocot, Kurzepa, & Musik, 2018;Kunnumakkara et al, 2017;Lephart, 2018;Ríos, Giner, Marín, & Recio, 2018;Rodríguez-Luna et al, 2018;Simitzis, 2018;Vega et al, 2017Vega et al, , 2018Vollmer et al, 2018;Yokota, Yahagi, & Masaki, 2018), promote skin repair (Bellot et al, 2019;Davinelli, Nielsen, & Scapagnini, 2018;Ferreira & Gomes, 2018;, and enhance diabeticassociated wound healing (Bellot et al, 2019;Ben-Nun, 2018;Cuadrado et al, 2019;Ferreira & Gomes, 2018;Gorini et al, 2019;Huang et al, 2018;Kocot et al, 2018;Kunnumakkara et al, 2017;Panahi et al, 2019;Ríos et al, 2018;Sanchez, Lancel, Boulanger, & Neviere, 2018;Vega et al, 2017;Vega et al, 2018;Vollmer et al, 2018).…”